Explore the Latest Active Ingredient ,Azithromycin Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Active Ingredient ,Azithromycin Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Active Ingredient ,Azithromycin Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Active Ingredient ,Azithromycin Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Active Ingredient ,Azithromycin Tenders and beyond.
11007457Conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient budesonide atc a07ea06 for the period march 1 2026 -Country: GermanyDeadline05 Jan 202911007427Conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient metronidazole atc d06bx01 for the period march 1 2026Country: GermanyDeadline05 Jan 202911007436Conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient potassium iodide atc h03ca01 for the period march 1 2Country: GermanyDeadline05 Jan 20297537423Cinnarizin und dimenhydrinatCountry: GermanyDeadline06 Mar 202711007454Conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient isosorbide mononitrate atc c01da14 for the period marcCountry: GermanyDeadline05 Jan 20298708582Completion of a non-exclusive discount agreement according to section 130a 8 sgb v for the active ingredient naproxen esomeprazol atc m01ae52 f d z 01 09 2025 - 31 08 2027Country: GermanyDeadline05 Jul 20288708573Completion of a non -exclusive discount agreement according to section 130a 8 sgb v on the active ingredient amifampridine atc n07xx05 for the period 01 09 2025 - 31 08 2027 plCountry: GermanyDeadline05 Jul 202810367860AlfacalcidolCountry: GermanyDeadline06 Dec 202710244223Medicines with the active ingredient raltegravir atc j05aj01Country: GermanyDeadline31 Oct 20279462970Medicines with the active ingredient infliximab atc l04ab02 - in the dosage form injection solutionCountry: GermanyDeadline31 Aug 202710244287Medicines with the active ingredient tafluprost atc s01ee05Country: GermanyDeadline31 Oct 202710243493Medicines with the active ingredient pazopanib atc l01ex03Country: GermanyDeadline31 Oct 202710243496Medicines with the active ingredient combination timolol and tafluprost atc s01ed70Country: GermanyDeadline31 Oct 20278416471Description : The health insurance companies (whether HEK and/or hkk are participating in the respective lot is determined by the name of the respective lot) aim to conclude discoCountry: GermanyDeadline31 Aug 202614039274Azithromycin Azithromycin Amoxicillin and clavulanic acid Amoxicillin and beta-lactamase inhibitor Amoxicillin and clavulanic acid Amoxicillin and beta-lactamase inhibitorCountry: UkraineDeadline12 Aug 202614083142Medicinal products for providing medical assistance Azithromycin Azithromycin Amiodarone Amiodarone Amoxicillin Clavulanic acid Amoxicillin Clavulanic acid MetamizoleCountry: UkraineDeadline14 Aug 202614061435Code DK 021 2015 33600000-6 Pharmaceutical products Valproic acid tablets 300 mg each INN Valproic acid Paracetamol oral suspension syrup 120 mg 5ml 100 ml INN ParacetamolCountry: UkraineDeadline13 Aug 202614047880Azithromycin lyophilisate powder for solution 500 mg each Azithromycin according to the code DK 021 2015 33600000-6-Pharmaceutical productsCountry: UkraineDeadline12 Aug 20264161790Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for those mentioned
Active ingredientCountry: GermanyDeadline31 Dec 202613381585Open house drug discount agreements for the active ingredient lisdexamfetamine without hard capsules in a pack size of 30 atc n06ba12Country: GermanyDeadline01 Jun 20284161673Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for those mentioned
Active ingredientCountry: GermanyDeadline31 Dec 202610645506Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Betahistin, ATC N07CA01 for the period 01/0Country: GermanyDeadline05 Dec 202810568451Open house drug discount agreements for the active ingredient methoxy-polyethylene glycol-epoetin beta, ATC B03XA03Country: GermanyDeadline30 Nov 202712487171Conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient dalbavancin atc j01xa04 for the period june 1st 2026Country: GermanyDeadline05 Apr 202910567940Open house drug discount agreements for the active ingredient pazopanib, ATC L01EX03Country: GermanyDeadline30 Nov 2027
